With another year of double-digit revenue growth in the books, Amgen’s longtime helmsman Robert Bradway continues to sit ...
Shah Capital intends to vote against Novavax's board nominees, executive compensation Activist investor Shah Capital plans to vote against the re-election of board nominees and the executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results